scholarly journals Six Minute Walk Test as a Monitoring tool in Chronic Obstructive Pulmonary Disease on Pulmonary Rehabilitation

2013 ◽  
Vol 2 (2) ◽  
pp. 35-41
Author(s):  
Vignan Kumar Gali Prakash ◽  
Sujath Gogineni ◽  
Rajesh Kumar ◽  
Mahaboob V Shaik
Keyword(s):  
Pulmonary Rehabilitation ◽  
Forced Expiratory Volume ◽  
Chronic Obstructive ◽  
Walk Test ◽  
Walk Distance ◽  
Obstructive Pulmonary Disease ◽  
Six Minute Walk Test ◽  
The Mean ◽  
Minute Walk Distance ◽  
Minute Walk

Background and Aims- The six minute walk test is widely used as an outcome measure in pulmonary rehabilitation programs. The objective of this study is to report the magnitude of change in the six minute walk test with test repetition in patients with chronic obstructive pulmonary disease on pulmonary rehabilitation program. Methods: A prospective study of 51 patients with moderate to very severe COPD was carried out. Clinical examination, spirometry, six minute walk distance were done. All were advised regular follow up visits at three, six and twelve months. Results: Four (8%) very severe cases completed all visits and one in those showed improvement in Forced Expiratory Volume in 1 second by 6% and six minute walk distance by 71 metres. Seven (31.37%) severe cases completed all visits; showed improvement in Forced Expiratory Volume in 1 second by 2.5%; the distance walked was a mean 381.5 metres and this was 2.5 % improvement over base line walking distance. Six (11%) moderately severe cases completed the study; the mean distance walked at the end of the study was 451 metres, which is an improvement of 53% and the mean change in Forced expiratory volume in 1 second was <2%. Totally, the mean of modified Burden of Lung disease Dyspnoea scale was 1.7 (baseline) and 4 (after the test). Conclusions: These findings support the recommendation of practice six minute walk test at baseline assessment in order to provide an accurate measure of the effects of rehabilitation on six minute walk distance.DOI: http://dx.doi.org/10.3126/jaim.v2i2.8774 Journal of Advances in Internal Medicine 2013;02(02):35-41.

scholarly journals Oxygen desaturation during the six-minute walk test in COPD patients

2014 ◽  
Vol 40 (3) ◽  
pp. 222-228 ◽  
Author(s):  
Maria Ângela Fontoura Moreira ◽  
Gabriel Arriola de Medeiros ◽  
Francesco Pinto Boeno ◽  
Paulo Roberto Stefani Sanches ◽  
Danton Pereira da Silva Júnior ◽  
...  
Keyword(s):  
Supplemental Oxygen ◽  
Walk Test ◽  
Walk Distance ◽  
Six Minute Walk Test ◽  
Copd Patients ◽  
The Mean ◽  
Minute Walk Distance ◽  
Minute Walk ◽  
Worse Prognosis ◽  
Severe Copd

Objective: To evaluate the behavior of oxygen saturation curves throughout the six-minute walk test (6MWT) in patients with COPD. Methods: We included 85 patients, all of whom underwent spirometry and were classified as having moderate COPD (modCOPD, n = 30) or severe COPD (sevCOPD, n = 55). All of the patients performed a 6MWT, in a 27-m corridor with continuous SpO2 and HR monitoring by telemetry. We studied the SpO2 curves in order to determine the time to a 4% decrease in SpO2, the time to the minimum SpO2 (Tmin), and the post-6MWT time to return to the initial SpO2, the last designated recovery time (RT). For each of those curves, we calculated the slope. Results: The mean age in the modCOPD and sevCOPD groups was 66 ± 10 years and 62 ± 11 years, respectively. At baseline, SpO2 was > 94% in all of the patients; none received supplemental oxygen during the 6MWT; and none of the tests were interrupted. The six-minute walk distance did not differ significantly between the groups. The SpO2 values were lowest in the sevCOPD group. There was no difference between the groups regarding RT. In 71% and 63% of the sevCOPD and modCOPD group patients, respectively, a ≥ 4% decrease in SpO2 occurred within the first minute. We found that FEV1% correlated significantly with the ΔSpO2 (r = −0.398; p < 0.001), Tmin (r = −0.449; p < 0.001), and minimum SpO2 (r = 0.356; p < 0.005). Conclusions: In the sevCOPD group, in comparison with the modCOPD group, SpO2 was lower and the Tmin was greater, suggesting a worse prognosis in the former.

scholarly journals Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study

PLoS ONE ◽  
2021 ◽  
Vol 16 (9) ◽  
pp. e0257040
Author(s):  
Dararat Eksombatchai ◽  
Thananya Wongsinin ◽  
Thanyakamol Phongnarudech ◽  
Kanin Thammavaranucupt ◽  
Naparat Amornputtisathaporn ◽  
...  
Keyword(s):  
Cohort Study ◽  
Prospective Cohort ◽  
Severe Pneumonia ◽  
Walk Test ◽  
Mild Symptom ◽  
Walk Distance ◽  
Six Minute Walk Test ◽  
The Mean ◽  
Minute Walk Distance ◽  
Minute Walk

Objectives To study abnormality of spirometry, six-minute walk distance, and chest radiograph among patients recovered from Coronavirus Disease 2019 (COVID-19). Methods and study design A prospective cohort study was conducted in 87 COVID-19 confirmed cases who recovered and discharged from a medical school hospital in Thailand. At the follow-up visit on day 60 after onset of symptoms, patients underwent an evaluation by spirometry (FVC, FEV1, FEV1/FVC, FEF25-75, and PEF), a six-minute-walk test (6MWT), and a chest radiograph. Results There were 35 men and 52 women, with a mean age of 39.6±11.8 years and the mean body mass index (BMI) was 23.8±4.3 kg/m2. Of all, 45 cases had mild symptoms; 35 had non-severe pneumonia, and 7 had severe pneumonia. Abnormality in spirometry was observed in 15 cases (17.2%), with 8% of restrictive defect and 9.2% of obstructive defect. Among the patients with an abnormal spirometry, the majority of the cases were in the severe pneumonia group (71.4%), compared with 15.6% in the non-severe pneumonia group, and 10.2% in the mild symptom group (p = 0.001). The mean six-minute-walk distance (6MWD) in the mild symptom and non-severe pneumonia groups was 538±56.8 and 527.5±53.5 meters, respectively. Although the severe pneumonia group tended to have a shorter mean 6-min walking distance, but this was not statistically significant (p = 0.118). Twelve patients (13.8%) had abnormal chest radiographs that showed residual fibrosis. This abnormality was more common in the severe pneumonia group (85.7%) and in others (7.5%) (p<0.001). Conclusions Abnormal spirometry was noted in 17.2% of COVID-19 survivors with both restrictive and obstructive defects. Severe COVID-19 pneumonia patients had higher prevalence rates of abnormal spirometry and residual fibrosis on the chest radiographs when compared to patients in the mild symptom and non-severe pneumonia groups.

scholarly journals Correlation between 6-minute walk distance and spirometry parameters in stable chronic obstructive pulmonary disease patients

2018 ◽  
Vol 7 (1) ◽  
pp. 34
Author(s):  
Ruchita B. Hajare ◽  
Raziya Nagarwala ◽  
Ashok Shyam ◽  
Parag Sancheti
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Strong Positive Correlation ◽  
Walk Test ◽  
Cross Sectional ◽  
Obstructive Pulmonary Disease ◽  
Six Minute Walk Test ◽  
Tertiary Center ◽  
Minute Walk

Background: Six minute walk test (6MWT) is a sub-maximal exercise test, used as a clinical indicator of the functional capacity, in patients with cardiopulmonary diseases. It is simple, objective and reproducible test. The present study was designed to assess correlation of six minute walk test with spirometry parameters, in patients with chronic obstructive pulmonary disease.Methods: In this cross sectional study, fifty patients diagnosed with chronic obstructive pulmonary disease (GOLD criteria) coming to tertiary center were recruited according to inclusion and exclusion criteria. All patients underwent spirometric measurement. Spirometric indices including FEV1, FVC, FEV1/FVC and MVV were tested using computerized spirometer. 6MWT was performed following American Thoracic Society (ATS) guidelines. Percent (%) predicted 6MWD was calculated. Correlation between spirometry and 6MWT was assessed.Results: It was found that correlation between 6MWT and spirometry is statistically significant. There is significant strong positive correlation between percent predicted 6MWD and FEV1 (r=0.850 and p= <0.001), whereas there is significant moderate correlation between percent predicted 6MWD and FVC (r=0.554 and p= <0.001), FEV1/FVC (r=0.509 and p= <0.001) and MVV (r=0.615 and p= <0.001).Conclusions: In chronic obstructive pulmonary disease, percent predicted 6mwd significantly correlated with the spirometry parameters (FEV1, FVC, FEV1/FVC, and MVV). 6MWD decreases as there is decline in the pulmonary function. 6MWT can be a useful replacement of spirometry in assessment of severity of COPD.

scholarly journals Correlation of spirometry and six minute walk test in patients with chronic obstructive pulmonary disease from Sundargarh, Odisha, India

2019 ◽  
Vol 8 (1) ◽  
pp. 205
Author(s):  
Yara Dinakar ◽  
Pradeep Panchadi Kiran ◽  
Akshaya K. Mohanty ◽  
Praveen Kishore Sahu ◽  
Anita Mohanty
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Significant Positive Correlation ◽  
Significant Negative Correlation ◽  
Chronic Obstructive ◽  
Walk Test ◽  
Obstructive Pulmonary Disease ◽  
Positive Correlation ◽  
Six Minute Walk Test ◽  
Copd Patients ◽  
Minute Walk

Background: Six‑Minute Walk Test (6MWT) is a simple, objective, reproducible test which correlated well with different spirometric indices, and thus able to predict severity of Chronic Obstructive Pulmonary Disease (COPD) and can replace spirometry in resource poor set‑up. Here, author evaluated the correlation of 6 minute walk distance (6MWD) with spirometric indices in COPD patients and the potential of 6MWT as an alternative to the assessment of severity of COPD.Methods: This cross-sectional observational study included a total of 80 COPD patients, diagnosed by GOLD criteria (Post bronchodilator FEV1/ FVC ratio <0.7). Modified Medical Research Council (mMRC) grading was used (age, weight, height, body mass index- BMI and breathlessness) and all the patients underwent spirometric measurement of FEV1, FVC and FEV1/ FVC ratio and tests were repeated after bronchodilation using 200-400 μg of salbutamol. 6MWT was performed following American Thoracic Society (ATS) protocol of 6MWT and distance was measured in meters.Results: Author found significant negative correlation of 6MWT with age (r=-0.384, p=0.00) and mMRC grading of dyspnea (r=-0.559, p=0.00) and significant positive correlation with height (r=0.267, p=0.019) and weight (r=0.293, p=0.008). Significant positive correlation of 6MWD was noted with post bronchodilator FEV1(r=0.608, p=0.00), FEV1% (r=0.429, p=0.00), FVC (r=0.514 p=0.00), FVC% (r=0.313 p=0.005), FEV1/FVC % (r=0.336, p=0.001). Positive correlation was also observed between 6MWT and BMI but statistically insignificant (r=0.177, p=0.116). There was significant negative correlation between 6MWT and GOLD staging (r=-0.536, p=0.00).Conclusions: This finding concludes that 6MWT can be used for the assessment of severity of disease in COPD patients in places where spirometry is not available.

scholarly journals Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease

2013 ◽  
Vol 187 (4) ◽  
pp. 382-386 ◽  
Author(s):  
Michael I. Polkey ◽  
Martijn A. Spruit ◽  
Lisa D. Edwards ◽  
Michael L. Watkins ◽  
Victor Pinto-Plata ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Walk Test ◽  
Obstructive Pulmonary Disease ◽  
Six Minute Walk Test ◽  
Minute Walk
Sign in / Sign up

Export Citation Format

Share Document